Gene therapy for surfactant protein B deficiency using recombinant AAV

Documents similaires

• Gene therapy for surfactant protein B deficiency using recombinant AAV vectors
  par: Meyer-Berg, H
  Publié: (2021)
• A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
  par: Munis, AM, et autres
  Publié: (2020)
• A human surfactant B deficiency air-liquid interface cell culture model suitable for gene therapy applications
  par: Altar M. Munis, et autres
  Publié: (2021-03-01)
• Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
  par: Meyer-Berg, H, et autres
  Publié: (2020)
• Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
  par: Helena Meyer-Berg, et autres
  Publié: (2020-10-01)